omahahilo| Huahai Pharmaceutical: Busulan injection obtained drug registration certificate

News summary

huahai pharmaceuticalomahahilo: Busulan injection obtained drug registration certificate Securities Times e Company News, Huahai Pharmaceutical (600521) announced on the evening of April 23 that the company recently received the drug registration certificate for Busulan injection approved and issued by the State Food and Drug Administration. Busulfan injection is suitable for combination with cyclophosphamide,omahahilo...

Newsletter text

Huahai Pharmaceutical: Busulan injection obtained drug registration certificate Securities Times e Company News, Huahai Pharmaceutical (600521) announced on the evening of April 23 that the company recently received the drug registration certificate of Busulan injection approved and issued by the State Food and Drug Administration. Busulfan injection is suitable for combination with cyclophosphamide as a pretreatment regimen before hematopoietic progenitor cell transplantation in chronic myeloid leukemia allogeneic patients.

Tags:

Prev: egtjackpot| Industry ETF weathervane 丨 Foreign investment is leading, and China-Pacific Internet ETF's half-day increase is "skyrocketing" by more than 3.5%
Next: hitboxarcade| Qitian Technology (300061.SZ): Net loss in the first quarter was 5.7141 million yuan